Total Holdings
46
Portfolio diversification across 46 positions
HRTS
(NASDAQ)Tema Heart & Health ETF
$36.05-- (--)
Loading... - Market loading
HRTS ETF Holdings: Tema Heart & Health ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$56.81M
Total fund assets
Expense Ratio
0.75%
Annual management fee
Fund Issuer
Tema
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 47 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Eli Lilly and Company | Stock | 10.72% |
| 2 | O OTC:RHHBY | Roche Holding AG | Stock | 5.35% |
| 3 | O OTCQX:RHHBY | Roche Holding AG | Stock | 4.73% |
| 4 |  | Johnson & Johnson | Stock | 4.66% |
| 5 | L LON:AZN | AstraZeneca PLC | Stock | 4.40% |
| 6 |  | UnitedHealth Group Incorporated | Stock | 4.36% |
| 7 |  | Thermo Fisher Scientific Inc. | Stock | 4.30% |
| 8 | L LSE:AZN | AstraZeneca PLC | Stock | 4.25% |
| 9 |  | Merck & Co., Inc. | Stock | 4.12% |
| 10 |  | Abbott Laboratories | Stock | 3.74% |
| 11 |  | Gilead Sciences, Inc. | Stock | 3.61% |
| 12 | S SWX:NOVN | Novartis AG | Stock | 3.31% |
| 13 |  | Danaher Corporation | Stock | 3.09% |
| 14 |  | Boston Scientific Corporation | Stock | 3.06% |
| 15 |  | Medtronic plc | Stock | 3.01% |
| 16 |  | AbbVie Inc | Stock | 2.93% |
| 17 |  | Vertex Pharmaceuticals Incorporated | Stock | 2.84% |
| 18 | C CPH:NOVO.B | Novo Nordisk A/S | Stock | 2.80% |
| 19 | L LSE:0QIU | Novo Nordisk A/S Class B | Stock | 2.53% |
| 20 |  | Arrowhead Pharmaceuticals, Inc | Stock | 2.49% |
| 21 |  | BridgeBio Pharma, Inc | Stock | 2.25% |
| 22 |  | Revolution Medicines, Inc | Stock | 2.14% |
| 23 |  | Bristol-Myers Squibb Company | Stock | 2.03% |
| 24 |  | Regeneron Pharmaceuticals, Inc. | Stock | 2.03% |
| 25 |  | Amgen Inc. | Stock | 2.01% |
| 26 |  | Crinetics Pharmaceuticals Inc | Stock | 2.01% |
| 27 |  | McKesson Corporation | Stock | 1.84% |
| 28 |  | Ionis Pharmaceuticals, Inc | Stock | 1.77% |
| 29 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 1.73% |
| 30 | T TYO:4519 | Chugai Pharmaceutical Co., Ltd. | Stock | 1.73% |
| 31 |  | Teva Pharmaceutical Industries Limited | Stock | 1.70% |
| 32 |  | Madrigal Pharmaceuticals, Inc | Stock | 1.65% |
| 33 |  | Intuitive Surgical, Inc | Stock | 1.63% |
| 34 |  | Edwards Lifesciences Corporation | Stock | 1.56% |
| 35 |  | Alnylam Pharmaceuticals, Inc | Stock | 1.55% |
| 36 |  | Cytokinetics, Incorporated | Stock | 1.55% |
| 37 |  | Insmed Incorporated | Stock | 1.51% |
| 38 |  | Insulet Corporation | Stock | 1.29% |
| 39 |  | Scholar Rock Holding Corp | Stock | 1.11% |
| 40 |  | Masimo Corporation | Stock | 1.10% |
| 41 |  | Ascendis Pharma AS | Stock | 1.10% |
| 42 |  | Neurocrine Biosciences, Inc | Stock | 1.00% |
| 43 |  | Viking Therapeutics Inc | Stock | 0.96% |
| 44 |  | DexCom, Inc | Stock | 0.95% |
| 45 | C CO:ZEAL | Zealand Pharma A/S | Stock | 0.77% |
| 46 |  | Mineralys Therapeutics Inc. Common Stock | Stock | 0.44% |
| 47 |  | Intellia Therapeutics, Inc | Stock | 0.24% |